Albumin, in particular, as either a drug conjugate (Cranmer, 2019) or nanocarrier (An and Zhang, 2017), can improve circulation time of the drug (Karami et al., 2020), facilitate increased tumor tissue accumulation via the enhanced permeability and retention (EPR) effect (Kimura et al., 2018), and overcome drug resistance (Onafuye et al., 2019). Here, ALB is linked to neoplasm.